← Back
Data updated: Mar 10, 2026
AIZANT
Pharmaceuticals
AIZANT is a generic drug manufacturer with 6 FDA-approved products.
2019
Since
6
Drugs
-
Trials
14
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ALBUTEROL SULFATE 2025-12-01
ALBUTEROL SULFATE 2025-11-21
Labeling
PIRFENIDONE 2025-08-11
ALBUTEROL SULFATE 2025-03-12
PIRFENIDONE 2025-02-04
Labeling
PIRFENIDONE 2025-02-04
Labeling
PIRFENIDONE 2024-12-18
ELIGLUSTAT TARTRATE 2024-12-10
PIRFENIDONE 2024-11-26
Labeling
ELIGLUSTAT TARTRATE 2024-07-10
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (3)
Company Info
- First Approval
- 2019-03-15
- Latest
- 2022-07-21
- Applications
- 6